We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Selling Pfizer's old headquarters just got a lot more attractive, according to the Post, which said recent rezoning will allow a much taller building to rise in its place, making the site more valuable.